Medicine & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aarhus University Hospital
Reports from Denmark, the the Netherlands and Belgium describe recent advances in melanoma research
June 2nd, 2006
Data on melanoma are outlined in reports from Denmark, the the Netherlands and Belgium. Study 1: Progression of metastatic melanoma was reduced by intratumoral injections of C Cure 709. According to a study from Denmark, "We did a phase I dose-escalation trial to evaluate the feasibility and safety of intratumoral injections of C Cure 709, an allogeneic, continuous CTL cell line that, restricted by HLA-A2, recognizes MART-1-positive tumor cells through transduction with a T-cell receptor encoding gene. Cells were administered intratumorally in 4 dose levels ranging from 108 to 109 cells/d on days 1, 4, 7, 10, 14, and 28 of each...
Source: Medicine & Law Weekly (2006-06-02)
|
